| BGT Stock | | | 0.04 0.01 16.22% |
Director
AFA1M AFAIM is Exec Director of Bio Gene Technology
| Address | 400 Collins Street, Melbourne, VIC, Australia, 3000 |
| Phone | 61 3 9068 1062 |
| Web | https://www.bio-gene.com.au |
Bio Gene Management Efficiency
The company has return on total asset
(ROA) of
(0.4461) % which means that it has lost $0.4461 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.8014) %, meaning that it generated substantial loss on money invested by shareholders. Bio Gene's management efficiency ratios could be used to measure how well Bio Gene manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Bio Gene's
Total Current Liabilities is comparatively stable compared to the past year.
Liabilities And Stockholders Equity is likely to gain to about 5
M in 2024, whereas
Non Current Liabilities Total is likely to drop slightly above 21.4
K in 2024.
Similar Executives
| Found 1 records | DIRECTOR Age |
| P MSc | De Grey Mining | 55 |
Bio Gene Technology (BGT) is traded on Australian Securities Exchange in Australia and employs 6 people. Bio Gene is listed under Fertilizers & Agricultural Chemicals category by Fama And French industry classification.
Management Performance
Bio Gene Technology Leadership Team
Elected by the shareholders, the Bio Gene's board of directors comprises two types of representatives: Bio Gene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bio. The board's role is to monitor Bio Gene's management team and ensure that shareholders' interests are well served. Bio Gene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bio Gene's outside directors are responsible for providing unbiased perspectives on the board's policies.
Bio Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bio Gene a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Bio Stock Analysis
When running Bio Gene's price analysis, check to
measure Bio Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Gene is operating at the current time. Most of Bio Gene's value examination focuses on studying past and present price action to
predict the probability of Bio Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Gene's price. Additionally, you may evaluate how the addition of Bio Gene to your portfolios can decrease your overall portfolio volatility.